ISCOMs: An adjuvant with multiple functions

Journal of Leukocyte Biology

Volumn 64, Issue 6, 1998, Pages 713-723

  Sjölander, Anders ^a   Cox, John C ^a   Barr, Ian G ^a  

^a CSL LIMITED   (Australia)

Author keywords

Antibody and T cell response; Immunostimulating complex; Quillaia saponaria; Saponin; Triterpene glycosides; Vaccine

Indexed keywords

ANTIGEN; CHOLESTEROL; CYTOKINE; GANGLIOSIDE GM2; IMMUNOLOGICAL ADJUVANT; ISCOM; ISCOMATRIX; ISCOPREP 703; KEYHOLE LIMPET HEMOCYANIN; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICROSPHERE; OVALBUMIN; PHOSPHOLIPID; QUIL A; SAPONIN; TUMOR VACCINE; UNCLASSIFIED DRUG; VACCINE; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; FEVER; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; INJECTION PAIN; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALAISE; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

ANIMALIA; QUILLAIA; QUILLAIA SAPONARIA; SAPONARIA;

EID: 0031730080     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.64.6.713     Document Type: Review

References (152)

1. Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., Osterhaus, A. (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308, 457-460.
2. Barr, I. G., Mitchell, G. F. (1996) ISCOMs (immunostimulating complexes): The first decade. Immunol. Cell Biol. 74, 8-25.
3. Claassen, I., Osterhaus, A. (1992) The iscom structure as an immune-enhancing moiety: experience with viral systems. Res. Immunol. 143, 531-541
4. Bates, J., Ackland, J., Coulter, A., Cox, J., Drane, D., Macfarlan, R., Varigos, J., Wong, T.-Y., Woods. W. (1996) Iscom™ adjuvant - a promising adjuvant for influenza virus vaccines. In Options for the Control of Influenza III (L. E. Brown, A. W. Hampson, and R. G. Webster, eds.), Amsterdam: Elsevier, 661-667.
5. Rimmelzwaan, G. F., Osterhaus, A. D. M. E. (1995) A novel generation of viral vaccines based on ISCOM matrix. In Vaccine Design, the Subunit and Adjuvant Approach (M. F. Powell and M. J. Newman, eds.), New York: Plenum, 543-558.
6. Tomasi, M., Hearn, T. L. (1996) ISCOMs, liposomes, and oil based vaccine delivery systems. In Mucosal Vaccines (H. Kiyono, P. L. Ogra, and J. R. McGhee eds.), San Diego: Academic, 175-186.
7. Kersten, G. F. A., Teerlink, T., Derks, H. J. G. M., Verkleij, A. J., van Wezel, T. L., Crommelin, D. J. A., Beuvery, E. C. (1988) Incorporation of the major outer membrane protein of Neisseria gonorrhoeae in saponinlipid complexes (Iscoms): Chemical analysis, some structural features, and comparison of their immunogenicity with three other antigen delivery systems. Infect. Immun. 56, 432-438.
8. Morein, B., Lövgren, K., Höglund, S., Sundquist, B. (1987) The ISCOM: an immunostimulating complex. Immunol. Today 8, 333-338.
9. Özel, M., Höglund, S., Gelderblom, H. R., Morein, B. (1989) Quaternary structure of the immunostimulating complex (iscom). J. Ultrastruct. Mol. Struct. Res. 102, 240-248.
10. Villacrés-Eriksson, M. (1993) Induction of Immune Response by Iscoms. Uppsala, Sweden: Swedish University of Agricultural Sciences (Thesis).
11. Weijer, K., Pfauth, A., van Herwijnen, R., Jarrett, O., Meloen, R. H., Tomee, C., Osterhaus, A. D. M. E. (1993) Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene. Vaccine 11, 946-956.
12. Mougin, B., Bakouche, O., Gerlier, D. (1988) Humoral immune response elicited in rats by measles viral membrane antigens presented in liposomes and ISCOMs. Vaccine 6, 445-448.
13. Morein, B., Simons, K. (1985) Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes. Vaccine 3, 83-93
14. Cox, V., Coulter, A., Macfarlan, R., Beezum, L, Bates, J., Wong, T.-Y., Drane, D. (1997) Development of an influenza-ISCOM™ vaccine. In Vaccine Design: The Role of Cytokine Networks (G. Gregoriadis, ed.), New York: Plenum, 33-49.
15. Kersten, G. F. A., Spiekstra, A., Beuvery, E. C., Crommelin, D. J. A. (1991) On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim. Biophys. Acta 1062, 165-171.
16. Lövgren, K., Morein, B. (1988) The requirement of lipids for the formation of immunostimulating complexes (iscoms). Biotechnol. Appl. Biochem. 10, 161-172.
17. Dalsgaard, K. (1978) A study of the isolation and characterization of the saponin Quil A. Acta Vet. Scand. (Suppl.) 69, 1-40.
18. Dalsgaard, K., Hilgers, L., Trouvé, G. (1990) Classical and new approaches to adjuvant use in domestic food animals. Adv. Vet. Sci. Comp. Med. 35 121-160.
19. Kensil, C. A., Marciani, D. J., Beltz, G. A., Hung, C.-H. (1988) Saponin adjuvant. Patent Application WO 88/09336.
20. von Kartnig, T., Ri, C. Y. (1973) Dünnschichtchromatographische untersuchungen an den saponinen aus cortex Quillajae. Planta Med. 23, 269-271.
21. Higuchi, R., Tokimitsu, Y., Fujioka, T., Komori, T., Kawasaki, T., Oakenfull, D. G. (1987) Structure of the desacylsaponins obtained from the bark of Quillaja saponaria. Phytochem. 26, 229-235.
22. Maharaj, I., Froh, K. J., Campbell, J. B. (1986) Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin. Can. J. Microbiol. 32, 414-420.
23. Kensil, C. R., Patel, U., Lennick, M., Marciani, D. (1991) Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146, 431-437.
24. Kersten, G. (1990) Aspects of ISCOMS. Analytical, Pharmaceutical and Adjuvant Properties. Utrecht, The Netherlands: University of Utrecht (Thesis).
25. So, H.-S., Yoon, H.-S., Choi, D.-Y., Kwon, Y.-S., Sung, J.-H., Lee, T. G., Park, E.-S., Cho, H.-S., Lee, B. M., Cho, J. M., Ryu, W.-S. (1997) Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant Hepatitis B surface antigen. Mol. Cells 7, 178-186.
26. Rönnberg, B., Fekadu, M., Morein, B. (1995) Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix. Vaccine 13, 1375-1382.
27. Morein, B., Lövgren, K., Rönnberg, B., Sjölander, A., Villacrés-Eriksson, M. (1995) Immunostimulating complexes. Clinical potential in vaccine development. Clin. Immunother. 3, 461-475.
28. Sjölander, A., Baldwin, T. M., Curtis, J. M., Handman, E. (1998) Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response is required for generation of immunity to Leshmaniasis. J. Immunol. 160, 3949-3957.
29. Sundquist, B., Lövgren, K., Höglund, S., Morein, B. (1988) Influenza virus ISCOMs: biochemical characterization. Vaccine 6, 44-58.
30. Trudel, M., Nadon, F., Seguin, C., Boulay, G., Lussier, G. (1987) Vaccination of rabbits with a bovine herpes virus type 1 subunit vaccine: adjuvant effect of ISCOMs. Vaccine 5, 239-243.
31. Höglund, S., Dalsgaard, K., Lövgren, K., Sundquist, B., Osterhaus, A., Morein, B. (1989) Iscoms and immunostimulation with viral antigens. In Subcellular Biochemistry (R. J. Harris, ed.), New York: Plenum, 39-68.
32. de Vries, P., van Binnendijk, R. S., van der Marel, P., van Wezel, A. L., Voorma, H. O., Sundquist, B., Uytdehaag, F. G. C. M., Osterhaus, A. D. M. E. (1988) Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J. Gen. Virol. 69, 549-559.
33. Akerblom, L., Nara, P., Dunlop, N., Putney, S., Morein, B. (1993) HIV experimental vaccines based on the iscom technology using envelope and gag gene products. Biotechnol. Therapeut. 4, 145-161.
34. Pyle, S. W., Morein, B., Bess, J. W., Åkerblom, L., Nara, P. L., Nigida, S. M., Lerche, N. W., Robey, W. G., Fishinger, P. J., Arthur, L. O. (1989) Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein gp120. Vaccine 7, 465-473.
35. Morein, B., Ekström, J., Lövgren, K. (1990) Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms. J. Immunol. Meth. 128, 177-181.
36. + cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur. J. Immunol. 21, 1523-1527.
37. Mowat, A. M. CI., Donachie, A. M., Reid, G., Jarrett, O. (1991) Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunol. 72, 317-322.
38. Reid, G. (1992) Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid. Vaccine 10, 597-602.
39. Browning, M., Reid, G., Osborne, R., Jarrett, O. (1992) Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies. Vaccine 10, 585-590.
40. Kazanji, M., Laurent, F., Péry. P. (1994) Immune responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeira falciformis in ISCOMs. Vaccine 12, 798-804.
41. Pedersen, I. R., Bøg-Hansen, T. C., Dalsgaard, K., Heegaard, P. M. H. (1992) Iscom immunization with synthetic peptides representing measles virus hemagglutinin. Virus Res. 24, 145-169.
42. Lövgren, K., Lindmark, J., Pipkorn, R., Morein, B. (1987) Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier. J. Immunol. Meth. 98, 137-143.
43. Sjölander, A., Lövgren, K., Sto̊hl, S., Åslund, L., Hansson, M., Nygren, P.-Å., Larsson, M., Hagstedt, M., Wåhlin, B., Berzins, K., Uhlèn, M., Morein, B., Perlmann, P. (1991) High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. Vaccine 9, 443-450.
44. Larsson, M., Lövgren, K., Morein, B. (1993) Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms. J. Immunol. Meth. 162, 257-260.
45. Lövgren, K., Larsson, M. (1994) Conjugation of synthetic peptides to carrier ISCOMs: factors affecting the immunogenicity of the conjugate. J. Immunol. Meth. 173, 237-243.
46. Weiss, H. P., Stitz, L., Becht, H. (1990) Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein. Arch. Virol. 114, 109-120.
47. Rimmelzwaan, G. F., Siebelink, K. H. J., Huisman, R. C., Moss, B., Francis, M. J., Osterhaus, A. D. M. E. (1994) Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes. J. Gen. Virol. 75, 2097-2102.
48. + cytotoxic T cells. Vaccine 12, 73-80.
49. + cytolytic T cells and confers protection to infection. Immunol. Lett. 40, 101-104.
50. Cleland, J. L. (1995) Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systems. In Vaccine Design: The Subunit and Adjuvant Approach (M. F. Powell and M. J. Newman, eds.), New York: Plenum, 439-462.
51. Kensil, C. R. (1996) Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Systems 13, 1-55.
52. Powell, M. F., Cleland, J. L., Eastman, D. J., Lim, A., Murthy, K., Newman, M. J., Nunberg, J. H., Weissburg, R. P., Vennari, J. C., Wrin, T. (1994) Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons. AIDS Res. Hum. Retroviruses 10 (Suppl. 2), S105-S108.
53. George, A. J. (1965) Legal status and toxicity of saponins. Fd. Cosmet. Toxicol. 3, 85-91.
54. Coulson, C., Evans, R. (1960) The effect of saponins, sterols and linoleic acid on weight increase of growing rats. Br. J. Nutr. 14, 121-134.
55. Tschesche, R., Wulff, G. (1973) Chemie und biologie der saponinen. In Fortschiritte der Chemie Organischer Naturstoffe Vol. 30 (W. Herz, H. Grisebach, and G. Kirby, eds.), New York: Springer-Verlag, 461-496.
56. Flebbe, L. M., Braley-Mullen, H. (1986) Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Cell. Immunol. 99, 119-127.
57. Stieneker, F., Kersten, G., van Bloois, L. Crommelin, D. J. A., Hem, S. L., Lower, J., Kreuter, J. (1995) Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations. Vaccine 13, 45-53.
58. Osterhaus, A., Weijer, K., Uytdehaag, F., Knell, P., Jarrett, O., Åkerblom, L., Morein, B. (1989) Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine. Vaccine 7, 137-141.
59. Sundquist, B. G., Czifra, G., Stipkovits, L. (1996) Protective immunity induced in chicken by a single immunization with Mycoplasma gallisepticum immunostimulating complexes (ISCOMS). Vaccine 14, 892-897.
60. Clark, N., Kushner, N. N., Barrett, C. B., Kensil, C. R., Salsbury, D., Cotter, S. (1991) Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection. J. Am. Vet. Med. Assoc. 199, 1433-1443.
61. Ma, J., Bulger, P. A., Dante, S., van Riet Davis, D., Perilli-Palmer, B., Coughlin, R. T. (1995) Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes. J. Infect. Dis. 171, 909-915.
62. de Vries, P., Heeney, J. L., Boes, J., Dings, M. E. M., Hulskotte, E. G. J., Dubbes, R., Koornstra, W., ten Haaft, P., Åkerblom, L., Eriksson, S., Morein, B., Norley, S., Osterhaus, A. D. M. E. (1994) Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. Vaccine 12, 1443-1452.
63. Emery, D. L., Rothel, J. S., Wood, P. R. (1990) Influence of antigen and adjuvants on the production of gamma-interferon and antibody by ovine lymphocytes. Immunol. Cell Biol. 68, 127-136.
64. Vanselow, B. A., Abetz, I., Trenfield, K. (1985) A bovine ephemeral fever vaccine incorporating adjuvant Quil A: A comparative study using adjuvants Quil A, aluminium hydroxide gel and dextran sulphate. Vet. Rec. 117, 37-43.
65. Speijers, G. J. A., Danse, L. H. J. C., Beuvery, E. C., Strik, J. J. T. W. A., Vos, J. G. (1988) Local reactions of the saponin Quil A and a Quil A containing ISCOM measles vaccine after intramuscular injection of rats: A comparison with the effect of DPT-Polio vaccine. Fund. Appl. Toxicol. 10, 425-430.
66. Allison, A. C., Byars, N. E. (1986) An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Meth. 95, 157-168.
67. Atkinson, H. A. C., Johnson, I. T., Gee, J. M., Grigoriadou, F., Miller, K. (1996) Brown Norway rat model of food allergy: effect of plant components on the development of oral sensitization. Food Chem. Toxicol. 34, 27-32.
68. Black, L. (1977) The adjuvant activity of saponin and aluminium hydroxide for promoting reagins. J. Immunol. Meth. 15, 193-195.
69. Kind, L. S., Ramaika, C., Allaway, E. (1981) Antigenic, adjuvant and permeability enhancing properties of melittin in mice. Allergy 36, 155-160.
70. Kensil, C. R., Wu, J.-Y., Soltysik, S. (1995) Structural and immunological characterization of the vaccine adjuvant QS-21. In Vaccine Design: The Subunit and Adjuvant Approach (M. F. Powell and M. J. Newman, eds.), New York: Plenum, 525-541.
71. Watson, D. L. Watson, N. A., Fossum, C., Lövgren, K., Morein, B. (1992) Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leukocytes. Microbiol. Immunol. 36, 199-203.
72. Bergström-Mollaoglu, M., Lövgren, K., Åkerblom, L., Fossum, C., Morein, B. (1992) Antigen-specific increases in the number of splenocytes expressing MHC Class II molecules following restimulation with antigen in various physical forms. Scand. J. Immunol. 36, 565-574.
73. Villacres-Eriksson, M., Bergström-Mollaoglu, M., Kåberg, H., Lövgren, K., Morein, B. (1993) The induction of cell-associated and secreted interleukin-1 by iscoms, matrix or micelles in murine splenic cells. Clin. Exp. Immunol. 93, 120-125.
74. Behboudi, S., Morein. B., Villacres-Eriksson, M. (1996) In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids. Clin. Exp. Immunol. 105, 26-30.
75. Behboudi, S., Morein, B., Villacres-Eriksson, M. (1997) In vivo and in vitro induction of IL-6 by Quillaja saponaria Molina triterpenoid formulations. Cytokine 9, 682-687.
76. Villacres-Eriksson, M., Behboudi, S., Morgan, A. J. Trinchieri, G., Morein, B. (1997) Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response. Cytokine 9, 73-82.
77. Villacres-Eriksson, M. (1995) Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin. Exp. Immunol. 102, 46-52.
78. Claassen, I. J. T. M., Osterhaus, A. D. M. E., Claassen, E. (1995) Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune-stimulating complexes. Eur. J. Immunol. 25, 1446-1452.
79. Watson, D. L., Lövgren, K., Watson, N. A., Fossum, C., Morein, B., Höglund, S. (1989) Inflammatory response and antigen localization following immunization with influenza virus ISCOMs. Inflammation 13, 641-649.
80. Lövgren Bengtsson, K., Sjölander, A. (1996) Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant. Vaccine 14, 753-760.
81. Sjölander, A., Lövgren Bengtsson, K., Johansson, M., Morein, B. (1996) Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (Iscoms) containing human influenza virus envelope glycoproteins. Scand. J. Immunol. 43, 164-172.
82. Sjölander, A., Lövgren Bengtsson, K., Morein, B. (1997) Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins. Vaccine 15, 1030-1038.
83. Yamamura, M., Uyemura, K., Deans, R. J., Weinberg, K., Rea, T. H., Bloom, B. R., Modlin, R. L. (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254, 277-279.
84. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88, 7011-7015.
85. Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Dolan, M. J., Hendrix. C. W., Wolf, S. F., Shearer, G. M. (1993) Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262, 1721-1724.
86. Fossum, C., Bergström, M., Lövgren, K., Watson, D. L., Morein, B. (1990) Effect of Iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with Iscoms and/or matrix. Cell. Immunol. 129, 414-125.
87. Villacres-Ericksson, M., Bergström-Mollaoglu, M., Kåberg, H., Morein, B. (1992) Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms. Scand. J. Immunol.
88. + T cell responses by oral or parenteral immunization with ISCOMS. Eur. J. Immunol. 25, 2835-2841.
89. Sjölander, A., van't Land, B., Lövgren Bengtsson, K. (1997) Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-tike immune responses. Cell. Immunol. 177, 69-76.
90. Hassan, Y., Brewer, J. M., Alexander, J., Jennings, R. (1996) Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems. Vaccine 14, 1581-1589.
91. Dotsika, E., Karagouni, E., Sundquist, B., Morein, B., Morgan, A., Villacres-Eriksson, M. (1997) Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus Iscoms. Scand. J. Immunol. 45, 261-268.
92. Papadopoulou, G., Karagouni, E., Dotsika, E. (1998) ISCOMs vaccine against experimental leishmaniasis. Vaccine 16, 885-892.
93. Sjölander A., Baldwin, T. M., Curtis, J. M., Lövgren Bengtsson, K., Handman, E. Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection. Vaccine, In press.
94. Heinzel, F. P., Rerko, R. M., Ahmed, F., Pearlman, E. (1995) Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155, 730-739.
95. Scott, P. A., Eaton, W. C., Gause, X.-D., Hondowiczk, B. (1996) Early IL-4 production does not predict suseptibility to Leishmania major. Exp. Parasitol. 84, 178-187.
96. Smith, R. E., Donachie, A. M., McLaren, F. H., Mowat McI. (1998) Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-γ. Immunol. 93,
97. Valensi, J.-P. M., Carlson, J. R., Van Nest, G. A. (1994) Systemic cytokine profiles in BALB/c mice immunised with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 153, 4029-4039.
98. Raychaudhuri, S., Tonks, M., Carbone, F., Ryskamp, T., Morrow, W. J. W., Hanna, N. (1992) Induction of antigen-specific class I-restncted cytotoxic T cells by soluble proteins in vivo. Proc. Natl. Acad. Sci. USA 89, 8308-8312.
99. Dillon, S. B., Demuth, S. G., Schneider, M. A., Weston, C. B., Jones, C. S., Young, J. F., Scott, M., Bhatnaghar, P. K., LoCastro, S., Hanna, N. (1992) Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine 10, 309-318.
100. Zhou, F., Huang, L. (1993) Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes. Vaccine 11, 1139-1144.
101. Deres, K., Schild, H., Wiesmuller, K. H., Jung, G., Rammensee, H. G. (1989) In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342, 561-564.
102. + cytotoxic T cells by immunization with purified HIV-1 envelope proteins in ISCOMs. Nature 344, 873-875.
103. Maloy, K. J., Donachie, A. M., O'Hagan, D. T., Mowat, McI. (1994) Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunol. 81, 661-667.
104. van Binnendijk, R. S., van Baalen, C. A., Poelen, M. C. M., de Vries, P., Boes, J., Cerundolo, V., Osterhaus, A. D. M. E., UytdeHaag, F. G. C. M. (1992) Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I-and class II-restricted cytotoxic T cell recognition. J. Exp. Med. 176, 119-128.
105. Trudel, M., Nadon, F. Séguin, C., Brault, S., Lusignan, Y., Lemieux, S. (1992) Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Vaccine 10, 107-112.
106. Zugel, U., Schoel, B., Yamamoto, S., Hengel, H., Morein, B., Kaufmann, S. H. (1995) Cross-recognition by CD8 T cell receptor alpha beta cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur. J. Immunol. 25, 451-458.
107. Hulskotte, E. G., Rimmelzwaan, G. F., Boes, J., Bosch, M. L., Heeney, J. L., Norley, S. G., de Vries, P., Osterhaus, A. D. (1995) Antigenicity and immunogenicity of recombinant enveloped glycoproteins of SIVmac32H with different in vivo passage histories. Vaccine 13, 1187-1197.
108. Tarpey, I., Stacey, S. N., McIndoe, A., Davies, D. H. (1996) Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs). Vaccine 14, 230-236.
109. Jones, P. D., Tha Hla, R., Morein, B. Lövgren, K., Ada, G. L. (1988) Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (Iscoms). Scand. J. Immunol. 27, 645-652.
110. Hsu, S.-C., Schadeck, E. B., Delmas, A., Shaw, M., Steward, M. W. (1996) Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization. Vaccine 14, 1159-1166.
111. Mowat, A. McI., Maloy, K. J., Donachie, A. M. (1993) Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens. Immunol. 80, 527-534.
112. + cytotoxic T lymphocyte responses. J. Immunol. 148, 2357-2362.
113. Wu, J.-Y., Gardner, B. H., Murphy, C. I., Seals, J. R., Kensil, C. R., Recchia, J., Beltz, G. A., Newman, G. W., Newman, M. J. (1992) Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 148, 1519-1525.
114. + CTL in vivo with peptide vaccine constructs. J. Immunol. 152, 549-556.
115. Britt, W., Fay, J., Seals, J., Kensil C. (1995) Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice. J. Infect. Dis. 171, 18-25.
116. Hancock, G. E. Speelman, D. J., Frenchick, P. J., Mineo-Kuhn, M. M., Baggs, R. B., Hahn, D. J. (1995) Formulation of the purified fusion protein of respiratory syncitial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection. Vaccine 13, 391-400.
117. Fenton, R. G., Keller, C. J., Hanna, N., Taub, D. D. (1995) Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras expressing Escherichia coli. J. Natl. Cancer Inst. 87, 1853-1861.
118. Hulskotte, E. G. J., Geretti, A.-M., Siebelink, K. H. J., van Amerongen, G., Cranage, M. P., Rud, E. W., Norley, S. G., de Vries, P., Osterhaus, A. D. M. E. (1995) Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). J. Virol. 69, 6289-6296.
119. Newman, M. J., Munroe, K. J., Anderson, C. A., Murphy, C. I., Panicali, D. L., Seals, J. R., Wu, J. Y., Wyand, M. S., Kensil, C. R. (1994) Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251 gag and env vaccines containing QS-21 saponin adjuvant. AIDS Res. Hum. Retroviruses 10, 853-861.
120. Macatonia, S. E., Taylor, P. M., Knight, S. C., Askonas, B. A. (1989) Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169, 1255-1264.
121. Lundén, A., Lövgren Bengtsson, K., Sjölander, A., Uggla, A. (1996) Iscoms in parasitological research. Parasitol. Today 12, 320-323.
122. Ertürk, M., Jennings, R., Hockley, D., Potter, W. (1989) Antibody responses and protection in mice immunized with Herpes Simplex Virus type 1 antigen immune-stimulating complex preparations. J. Gen. Virol. 70, 2149-2155.
123. Barr, I. G., Sjölander, A., Cox, J. C. (1998) ISCOMs and other saponin based adjuvants. Adv. Drug Del. Rev. 32, 247-271.
124. Klaus, G. G., Pepys, M. B., Kitajima, K., Askonas, B. A. (1979) Activation of mouse complement by different classes of mouse antibody. Immunol. 38, 687-695.
125. Fanger, M. W., Shen, L., Graziano, R. F., Guyre, P. M. (1989) Cytotoxicity mediated by human Fc receptors for IgG. Immunol. Today 10, 92-99.
126. Heusser, C. H., Anderson, C. L., Grey, H. M. (1977) Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J. Exp. Med. 145, 1316-1327.
127. Bolmstedt, A., Sjölander, S., Hansen, J. E., Åkerblom, L., Hemming, A., Hu, S. L., Morein, B., Olofsson, S. (1996) Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response. J. Acquir. Immune Defic. Syndr. Hum. Retroviruses 12, 213-220.
128. Trudel, M., Nadon, F., Seguin, C., Simard, C., Lussier, G. (1989) Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus. Vaccine 7, 12-16.
129. Kodihalli, S., Sivanadan, V., Nagaraja, K. V., Shaw, D., Halvorson, D. A. (1994) A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection. Vaccine 12, 1467-1472.
130. Charles, S. D., Nagaraja, K. V., Sivanadan, V. (1993) A lipid-conjugated immunostimulating complex subunit vaccine against Salmonella infection in turkeys. Avian Dis. 37, 477-484.
131. Sjölander, A, Hansson, M., Lövgren, K., Wåhlin, B., Berzins, K., Perlmann, P. (1993) Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA. Parasite Immunol. 15, 355-359.
132. de Vries, P., Uytdehaag, F. G., Osterhaus, A. D. (1988) Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection. J. Gen. Virol. 69, 2071-2083.
133. Visser, I. K. G., Vedder, E. J., van de Bildt, M. W. G., Örvell, C., Barrett, T., Osterhaus, A. D. M. E. (1992) Canine distemper virus Iscoms induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1. Vaccine 10, 435-438.
134. Carlsson, U., Alenius, S., Sundquist, B. (1991) Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes. Vaccine 9, 577-580.
135. Lundén, A. (1995) Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms. Vet. Parasitol. 56, 23-25.
136. Morein, B., Belak, S., Soos, T., Rusvai, M., Mcgwire, B. S., Bognar, K. (1989) Iscom of viral envelope proteins protects against Aujeszky's disease. Vet. Microbiol. 20, 143-154.
137. Tulman, E. R., Garmendia, A. E. (1994) Delivery of pseudorabies virus envelope antigens in immunostimulating complexes (ISCOMs): Elicitation of neutralizing antibody responses in swine and protection in mice. Vaccine 12, 1349-1354.
138. York, I. A., Thorsen, J. (1992) Evaluation of a subunit vaccine for bovine adenovirus type 3. Am. J. Vet. Res. 53, 180-183.
139. Jackson, L. A., Opdebeeck, J. P. (1994) Quil A and ISCOM as adjuvants for midgut membrane antigens of Boophilus microplus. Appl. Parasitol. 35, 87-98.
140. Mumford, J. A., Jesset, D., Dunleavy, U., Wood, J., Hannant, D., Sundquist, B., Cook, R. F. (1994) Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 12, 857-863.
141. Hannant, D., Jessett, D. M., O'Neill, T., Dolby, C. A., Cook, R. F., Mumford, J. A. (1993) Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res. Vet. Sci. 54, 299-305.
142. Rimmelzwaan, G. F., Baars, M., van Beek, R., van Amerongen, G., Lövgren Bengtsson, K., Claas, E. C., Osterhaus, A. D. (1997) Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J. Gen. Virol. 78, 757-765.
143. Yeolekar, L. R., Banerjee, K. (1996) Immunogenicity of immunostimulating complexes of Japanese encephalitis virus in experimental animals. Acta Virol. 40, 245-250.
144. Osterhaus, A., de Vries, P., Morein, B., Åkerblom, L., Heeney, J. (1992) Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge. AIDS Res. Hum. Retroviruses 8, 1507-1510.
145. Berzins, K., Adams, S., Broderson, J. R., Chizzolini, C., Hansson, M., Lövgren, K., Millet, P., Morris, C. L., Perlmann, H., Perlmann, P., Sjölander, A., Ståhl, S., Sullivan, J. S., Troye-Blomberg, M., Wåhlin Flyg, B., Collins, W. E. (1995) Immunogenicity in Aotus monkeys of ISCOM formulated repeat sequences from the Plasmodium falciparum asexual blood stage antigen Pf155/RESA. Vaccine Res. 4, 121-133.
146. Snodgrass, D. R., Campbell, I., Mwenda, J. M., Chege, G., Suleman, M. A., Morein, B., Hart, C. A. (1995) Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination. Vaccine 13, 408-413.
147. van Binnendijk, R. S., Pooler, C. M., van Amerongen, G., de Vries, P., Osterhaus, A. D. M. E. (1997) Protective immunity in Macaques vaccinated with live attenuated recombinant and subunit vaccines in the presence of passively aquired antibodies. J. Infect. Dis. 175, 524-532.
148. Wahren, B., Nordlund, S., Åkesson, A., Sundqvist, V. A., Morein, B. (1987) Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus. Med. Microbiol. Immunol. 176, 13-19.
149. Nilsson, C., Thorstensson, R., Gilljam, G., Sjölander, S., Hild, K., Broliden, K., Åkerblom, L., Morein, B., Biberfeld, G., Putkonen, P. (1995) Protection against monkey-cell grown cell-free HIV-2 challenge in macaques immunized with native HIV-2 envelope glycoprotein gp125. Vaccine Res. 4, 165-175.
150. Putkonen, P., Björling, E., Åkerblom, L., Thorstensson, R., Lövgren, K., Benthin, L., Chiodi, F., Morein, B., Biberfeld, G., Norrby, E., Wigzell, H. (1994) Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine. J. Acquir. Defic. Syndr. 7, 551-559.
151. Morgan, A. J., Finerty, S., Lövgren, K., Scullion, F. T., Morein, B. (1988) Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes. J. Gen. Virol. 69, 2093-2096.
152. Livingston, P. O., Adluri, S. Helling, F., Yao, T. J., Kensil, C. R., Newman, M. J., Marciani, D. (1994) Phase 1 trial of immunological adjuvant QS-21 with GM2 ganglioside-keyhole limpet haemocynanin conjugate vaccine in patients with malignant melanoma. Vaccine 12, 1275-1280.